Maintenance Notice (2:30 - 3:00 AM March 8, 2026 UTC): The website is scheduled for maintenance. The website will be available, but some functions may experience errors. We appreciate your patience and understanding.
Product Document Searching Made Easy by 2D Code! | TCI Chemistry News March 2026 | [Product Highlights] MES Buffer Exhibiting Low Temperature... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 19171-19-8 | 产品编码: P2074
Pomalidomide
| 产品编码 | P2074 |
纯度/分析方法
|
>98.0%(HPLC) |
| 分子式/分子量 | C__1__3H__1__1N__3O__4 = 273.25 |
| 外观与形状(20°C) | 固体 |
储存温度
|
冷藏 (0-10°C) |
| 应避免的情况 | 加热 |
包装和容器
|
100MG-Glass Bottle with Plastic Insert (查看图片), 25MG-Glass Bottle with Plastic Insert (查看图片) |
| CAS RN | 19171-19-8 |
| Reaxys-RN | 8340987 |
| PubChem物质ID | 253660183 |
| Merck Index (14) | 135 |
| MDL编号 | MFCD12756407 |
技术规格
| Appearance | White to Yellow to Green powder to crystaline |
| Purity(HPLC) | min. 98.0 area% |
物性(参考值)
| 熔点 | 313 °C(dec.) |
GHS
| 象形图 |
|
| 信号词 | Warning |
| 危险性说明 | H361 : Suspected of damaging fertility or the unborn child. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
相关法规
| RTECS# | NR3397905 |
运输信息
| HS编码* | 2925.19-000 |
应用
A Potent Anti-Myeloma, Anti-Inflammatory and Immunomodulatory Agent, Pomalicomide
Pomalidomide (CC-4047), a thalidomide analog, is an immunomodulatory agent with numerous effects on the body's immune system, and has potent anti-myeloma and anti-inflammatory activities in vitro and in vivo. Pomalidomide inhibits the cytokines tumor necrosis factor-α (TNF-α), interleukins (IL) 1β, 6, 12, and granulocyte macrophage-colony stimulating factor (GM-CSF).
References
- Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity
- Lenalidomide and CC-4047 Inhibit the Proliferation of Malignant B Cells while Expanding Normal CD34+ Progenitor Cells
- The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
- Pharmacological properties of thalidomide and its analogues
- Pomalidomide therapy for myeloma
- Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
PubMed Literature
文档
技术文章
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。